Welcome to our dedicated page for Viavi Solutions SEC filings (Ticker: VIAV), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Viavi Solutions Inc. filings document operating results, material events, governance actions and capital-structure matters for a Nasdaq-listed technology company. Its Form 8-K disclosures include quarterly financial results, material definitive agreements, restructuring-related exit and disposal cost disclosures, and amendments to governing documents.
VIAVI regulatory records also cover senior convertible note transactions, exchanges of prior convertible notes, proxy and governance disclosures, shareholder voting matters, director elections, officer exculpation provisions, common stock registration details and related risk, ownership and corporate-control information.
Richard John Burns, a director of Viavi Solutions Inc. (VIAV), was granted 6,768 restricted stock units (RSUs) on 08/28/2025. The award carries a $0 purchase price and results in 6,768 shares of common stock beneficially owned following the transaction, held directly. The RSUs vest on the earlier of the one-year anniversary of the grant or the company’s next annual meeting of stockholders, and the RSUs have no expiration date. The Form 4 was signed by Donna T. Rossi as attorney-in-fact on 08/29/2025 and was filed as a single reporting person filing.
Viavi Solutions Inc. (VIAV) director Eugenia Corrales received an award of 6,768 restricted stock units (RSUs) on 08/28/2025. The RSUs were granted at a $0 exercise/conversion price and are reported as directly owned following the transaction, with 6,768 shares underlying the award. The units vest on the earlier of the one-year anniversary of the grant or the next annual meeting of stockholders, and the filing states there is no expiration date on the RSUs. The Form 4 was signed by an attorney-in-fact on behalf of the reporting person on 08/29/2025.
Form 144 filed for Viavi Solutions Inc. (VIAV) shows a proposed sale of 13,115 common shares through Morgan Stanley Smith Barney LLC, with an aggregate market value of $146,560.13. The filing lists the number of outstanding shares as 223,245,915 and identifies the approximate date of sale as 08/29/2025 on NASDAQ. The securities were acquired on 08/28/2025 as restricted stock from the issuer, with payment dated 08/28/2025. The filer reports no securities sold in the past three months. The filing includes the standard representation that the seller is not aware of undisclosed material adverse information and notes reliance possibilities for a Rule 10b5-1 trading plan if applicable. The issuer name and some filer contact details are not provided in the visible content.
Viavi Solutions Inc. (VIAV) submitted a Form 144 notice for a planned sale of 11,873 common shares valued at $132,693.84, to be executed approximately on 08/29/2025 on the NASDAQ. The shares represent a small portion of the company's common stock, with 223,245,915 shares outstanding, and were acquired as restricted stock from the issuer on 08/28/2025. The filing reports no sales by the seller in the past three months and indicates the transaction will be brokered by Morgan Stanley Smith Barney LLC. The filer attests they are not aware of undisclosed material adverse information and notes the usual Rule 10b5-1/attestation language on trading plans and criminal penalties for misstatements.
Viavi Solutions Inc. filed an 8-K reporting a material event and furnished two exhibits: an indenture dated August 20, 2025 between the company and U.S. Bank Trust Company, National Association as trustee, and the form of 0.625% Senior Convertible Notes due 2031 (included as part of the indenture). The filing lists the company’s principal contact information and is signed by Ilan Daskal, Chief Financial Officer, as the duly authorized officer. The exhibits indicate the company has documented the legal framework and the note terms for a convertible debt instrument carrying a stated interest rate of 0.625% and a 2031 maturity.
Viavi Solutions Inc. entered into privately negotiated exchange and subscription agreements to issue $250 million aggregate principal amount of new 0.625% Senior Convertible Notes due 2031. The deal includes about $100.9 million of new notes issued in exchange for approximately $97.5 million of its 1.625% Senior Convertible Notes due 2026 and about $149.1 million of new notes sold for cash to institutional investors under Securities Act exemptions. The company will cancel the exchanged 2026 notes and receive gross cash proceeds of about $149.1 million before fees. The new notes are convertible into cash and, if applicable, common stock at an initial rate of 72.5295 shares per $1,000 principal (a conversion price of roughly $13.79 per share, a 25% premium to the $11.03 closing price on August 13, 2025), with a current maximum of 22,665,450 shares issuable upon conversion.
Viavi Solutions Inc. amended a prior report to update the roles of two recently appointed independent directors. The Board appointed Richard Burns to the Compensation Committee. Eugenia Corrales was appointed to the Audit Committee and the Cybersecurity Steering Committee, with all appointments effective August 13, 2025.
The Board determined that both directors are independent under Securities and Exchange Commission and Nasdaq rules. It also concluded that Eugenia Corrales qualifies as an audit committee financial expert under Regulation S-K, reinforcing the Board’s financial oversight and cybersecurity governance capabilities.
Viavi Solutions Inc. agreed to issue $250 million aggregate principal amount of 0.625% Senior Convertible Notes due 2031, consisting of approximately $100.9 million of New Notes exchanged for about $97.5 million principal amount of its existing 1.625% Senior Convertible Notes due 2026 and approximately $149.1 million of New Notes sold for cash. After the Exchange Transactions, approximately $152.5 million principal amount of the 2026 Notes will remain outstanding.
The company expects to use net proceeds from the Subscription Transactions to repay a portion of the 2026 Notes upon maturity and expects the Transactions to close on or about August 20, 2025. In connection with the issuance of the New Notes, the company expects to repurchase approximately $30 million of common stock at $11.03 per share and the placement agent intends to purchase about $25 million of shares at a 5% discount to that price. Forms of the agreements and a press release are filed as exhibits.
Viavi Solutions Inc. filed an automatic shelf registration (Form S-3) dated August 11, 2025 that permits the company and selling security holders to offer from time to time a variety of securities including common stock, preferred stock, depositary shares, debt securities, warrants, purchase contracts, rights, and units. The prospectus states offerings will be made in one or more series and that specific terms will be provided in prospectus supplements. The company noted its common stock trades on Nasdaq under VIAV and closed at $10.93 per share on August 8, 2025.
Corporate details in the prospectus include headquarters in Chandler, Arizona, and authorized capital of 1,001,000,000 shares (1,000,000,000 common; 1,000,000 preferred). The board may designate and issue preferred stock without further stockholder action. Use of proceeds is described as for general corporate purposes with no specific planned uses; management will have broad discretion. The filing incorporates risk factors and discloses anti-takeover and indemnification provisions in the certificate of incorporation and bylaws.
Viavi Solutions Inc. provides network test, monitoring and assurance solutions and optical security and performance products across two reportable segments: Network and Service Enablement (NSE) and Optical Security and Performance Products (OSP), with segment reporting realigned effective March 30, 2025. NSE serves telecom, cloud, enterprise and defense markets; OSP supplies anti-counterfeiting pigments and 3D sensing optics used on banknotes in more than 100 countries.
Key facts disclosed include an aggregate market value of approximately $2.2 billion (Dec 28, 2024), 223,245,915 shares outstanding (July 26, 2025), ~3,600 employees, ~1,085 U.S. patents and 2,075 foreign patents with 1,164 pending, a TRIR of 0.08, a fiscal-2024 grant of $21.7 million over three years, manufacturing in China, France, Germany, the U.K. and the U.S., and contract manufacturers in China and Thailand. The company completed the Inertial Labs acquisition in January 2025 and disclosed a proposed acquisition of Spirent business lines (estimated close by end of Sept 2025, subject to customary conditions). Material risks highlighted include customer concentration (including a strategic alliance with SICPA), geopolitical and trade disruptions, supply-chain concentration, rapid technological change, cybersecurity threats, restructuring actions and increased leverage from issued notes (including convertible and senior notes).